There is no doubt that establishing state of the art is a challenge. It ranges from key information on the medical condition to a neutral, comprehensive analysis of treatment options, and culminates in a succinct yet comprehensive presentation that defines the currently accepted safety and performance standards against which the device is measured. Not surprisingly, common pitfalls include a perspective that is too broad and inclusion of too much detail, or a perspective that is too narrow, omitting relevant indications and alternative therapeutic options. An important critical aspect of the clinical evaluation that relies on state of the art data is also to appropriately define the position of the device within the currently available treatment portfolio.
To avoid such pitfalls, it can be helpful to develop a conceptual outline or “anatomy” of the state of the art section early during the review (see the figure below).
If you want to find out more about State of the Art according in MEDDEV 2.7/1 rev 4, you can download our full whitepaper.
June 17-21, 2019
Crowne Plaza Brussels – Le Palace, Brussels
Don’t miss out on the early bird discount – register before March 29th to get £300 off.
Save an additional 25% off your registration fee by clicking this link.
Already registered? We’ll see you there! Book at meeting with us at booth #9.